Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

Rapid Micro Biosystems, Inc.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

LEXINGTON, MASS., JULY 23, 2026 (GLOBE NEWSWIRE) -- RAPID MICRO BIOSYSTEMS, INC. (NASDAQ: RPID) (THE COMPANY), AN INNOVATIVE LIFE SCIENCES TECHNOLOGY COMPANY PROVIDING MISSION-CRITICAL AUTOMATION SOLUTIONS TO FACILITATE THE EFFICIENT MANUFACTURING AND FAST, SAFE RELEASE OF HEALTHCARE PRODUCTS, WILL RELEASE SECOND QUARTER 2026 FINANCIAL RESULTS PRIOR TO THE MARKET OPEN ON FRIDAY, AUGUST 7, 2026.

RAPID MICRO BIOSYSTEMS TO ANNOUNCE SECOND QUARTER 2026 FINANCIAL RESULTS ON AUGUST 7, 2026

LEXINGTON, MASS., JUNE 10, 2026 (GLOBE NEWSWIRE) -- RAPID MICRO BIOSYSTEMS, INC. (NASDAQ: RPID) (THE COMPANY), AN INNOVATIVE LIFE SCIENCES TECHNOLOGY COMPANY PROVIDING MISSION CRITICAL AUTOMATION SOLUTIONS TO FACILITATE THE EFFICIENT MANUFACTURING AND FAST, SAFE RELEASE OF HEALTHCARE PRODUCTS, TODAY ANNOUNCED THE GRANT ON JUNE 3, 2026, OF 60,000 RESTRICTED STOCK UNITS (RSUS) OF THE COMPANY'S CLASS A COMMON STOCK (COMMON STOCK) AS A MATERIAL INDUCEMENT TO EMPLOYMENT FOR A NEW EMPLOYEE. SUCH EQUITY AWARD WAS MADE UNDER THE COMPANY'S INDUCEMENT PLAN, AS AMENDED (THE INDUCEMENT PLAN) AND WAS APPROVED BY A MAJORITY OF THE INDEPENDENT DIRECTORS OF THE BOARD OF DIRECTORS OR A DULY AUTHORIZED COMMITTEE THEREOF IN ACCORDANCE WITH NASDAQ LISTING RULE 5635(C)(4). THE EQUITY AWARD IS SUBJECT TO THE TERMS AND CONDITIONS OF THE INDUCEMENT PLAN, AND THE TERMS AND CONDITIONS OF THE APPLICABLE RSU AWARD AGREEMENT COVERING THE GRANT.

RAPID MICRO BIOSYSTEMS ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)

BAIN CAPITAL LIFE SCIENCES AND ARMISTICE CAPITAL ARE INVESTING APPROXIMATELY $9.8 MILLION, WITH THE POTENTIAL OF UP TO APPROXIMATELY $32 MILLION IN THE EVENT THE WARRANTS OFFERED IN THIS OFFERING ARE EXERCISED, TO SUPPORT THE FUTURE SUCCESS OF THE COMPANY. CERTAIN DIRECTORS AND OFFICERS OF THE COMPANY ARE ALSO INVESTING IN A CONCURRENT REGISTERED OFFERING BAIN CAPITAL LIFE SCIENCES AND ARMISTICE CAPITAL ARE INVESTING APPROXIMATELY $9.8 MILLION, WITH THE POTENTIAL OF UP TO APPROXIMATELY $32 MILLION IN THE EVENT THE WARRANTS OFFERED IN THIS OFFERING ARE EXERCISED, TO SUPPORT THE FUTURE SUCCESS OF THE COMPANY. CERTAIN DIRECTORS AND OFFICERS OF THE COMPANY ARE ALSO INVESTING IN A CONCURRENT REGISTERED OFFERING

RAPID MICRO BIOSYSTEMS ANNOUNCES PRICING OF UP TO APPROXIMATELY $32 MILLION UNDERWRITTEN OFFERING

LEXINGTON, MASS., MAY 13, 2026 (GLOBE NEWSWIRE) -- RAPID MICRO BIOSYSTEMS, INC. (NASDAQ: RPID) (THE COMPANY), AN INNOVATIVE LIFE SCIENCES TECHNOLOGY COMPANY PROVIDING MISSION CRITICAL AUTOMATION SOLUTIONS TO FACILITATE THE EFFICIENT MANUFACTURING AND FAST, SAFE RELEASE OF HEALTHCARE PRODUCTS, TODAY ANNOUNCED ITS FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2026.

RAPID MICRO BIOSYSTEMS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS

LEXINGTON, MASS., MAY 06, 2026 (GLOBE NEWSWIRE) -- RAPID MICRO BIOSYSTEMS, INC. (NASDAQ: RPID) (THE COMPANY), AN INNOVATIVE LIFE SCIENCES TECHNOLOGY COMPANY PROVIDING MISSION-CRITICAL AUTOMATION SOLUTIONS TO FACILITATE THE EFFICIENT MANUFACTURING AND FAST, SAFE RELEASE OF HEALTHCARE PRODUCTS, WILL RELEASE FIRST QUARTER 2026 FINANCIAL RESULTS AFTER THE MARKET CLOSE ON WEDNESDAY, MAY 13, 2026.

RAPID MICRO BIOSYSTEMS TO ANNOUNCE FIRST QUARTER 2026 FINANCIAL RESULTS ON MAY 13, 2026

REPORTS RECORD FOURTH QUARTER 2025 TOTAL REVENUE OF $11.3 MILLION , REPRESENTING 37% GROWTH COMPARED TO FOURTH QUARTER 2024 REPORTS FULL YEAR 2025 TOTAL REVENUE OF $33.6MILLION , REPRESENTING 20% GROWTH COMPARED TO 2024 AMGEN EXPANDS GLOBAL GROWTH DIRECT SYSTEM ROLLOUT WITH SIGNIFICANT MULTI-SYSTEM ORDER IN THE FOURTH QUARTER 2025; WILL SPONSOR NORTH AMERICAN GROWTH DIRECT DAY IN THE SECOND QUARTER 2026 SAMSUNG BIOLOGICS CONTINUES TO EXPAND GROWTH DIRECT DEPLOYMENT ACROSS ITS MANUFACTURING NETWORK WITH A MEANINGFUL MULTI-SYSTEM ORDER IN THE FIRST QUARTER 2026 FOR THE FULL YEAR 2026, THE COMPANY EXPECTS TOTAL REVENUE IN THE RANGE OF $37.0 MILLION TO $41.0 MILLION INCLUDING A RANGE OF 30 TO 38 GROWTH DIRECT SYSTEM PLACEMENTS AND GROSS MARGIN PERCENTAGE OF APPROXIMATELY 20% LEXINGTON, MASS., MARCH 12, 2026 (GLOBE NEWSWIRE) -- RAPID MICRO BIOSYSTEMS, INC. (NASDAQ: RPID) (THE COMPANY), AN INNOVATIVE LIFE SCIENCES TECHNOLOGY COMPANY PROVIDING MISSION CRITICAL AUTOMATION SOLUTIONS TO FACILITATE THE EFFICIENT MANUFACTURING AND FAST, SAFE RELEASE OF HEALTHCARE PRODUCTS, TODAY ANNOUNCED ITS FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL YEAR ENDED DECEMBER 31, 2025.

RAPID MICRO BIOSYSTEMS REPORTS RECORD FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES 2026 GUIDANCE

COMPANIES DEEPEN PARTNERSHIP TO ADVANCE AUTOMATED, INTEGRATED MICROBIOLOGY QUALITY CONTROL COMPANIES DEEPEN PARTNERSHIP TO ADVANCE AUTOMATED, INTEGRATED MICROBIOLOGY QUALITY CONTROL

RAPID MICRO BIOSYSTEMS ANNOUNCES FOLLOW-ON MULTI-SYSTEM ORDER FROM SAMSUNG BIOLOGICS TO EXPAND DEPLOYMENT OF GROWTH DIRECT PLATFORM

LEXINGTON, MASS., MARCH 10, 2026 (GLOBE NEWSWIRE) -- RAPID MICRO BIOSYSTEMS, INC. (NASDAQ: RPID) (THE COMPANY), AN INNOVATIVE LIFE SCIENCES TECHNOLOGY COMPANY PROVIDING MISSION CRITICAL AUTOMATION SOLUTIONS TO FACILITATE THE EFFICIENT MANUFACTURING AND FAST, SAFE RELEASE OF HEALTHCARE PRODUCTS, TODAY ANNOUNCED THAT THE COMPANY WILL PARTICIPATE IN THE KEYBANC CAPITAL MARKETS HEALTHCARE FORUM.

RAPID MICRO BIOSYSTEMS TO PARTICIPATE IN KEYBANC CAPITAL MARKETS HEALTHCARE FORUM

LEXINGTON, MASS., FEB. 26, 2026 (GLOBE NEWSWIRE) -- RAPID MICRO BIOSYSTEMS, INC. (NASDAQ: RPID) (THE COMPANY), AN INNOVATIVE LIFE SCIENCES TECHNOLOGY COMPANY PROVIDING MISSION CRITICAL AUTOMATION SOLUTIONS TO FACILITATE THE EFFICIENT MANUFACTURING AND FAST, SAFE RELEASE OF HEALTHCARE PRODUCTS, TODAY ANNOUNCED THAT THE COMPANY WILL PRESENT AT THE TD COWEN 46TH ANNUAL HEALTH CARE CONFERENCE IN BOSTON, MA.

RAPID MICRO BIOSYSTEMS TO PRESENT AT TD COWEN 46TH ANNUAL HEALTH CARE CONFERENCE

LEXINGTON, MASS., FEB. 24, 2026 (GLOBE NEWSWIRE) -- RAPID MICRO BIOSYSTEMS, INC. (NASDAQ: RPID) (THE COMPANY), AN INNOVATIVE LIFE SCIENCES TECHNOLOGY COMPANY PROVIDING MISSION-CRITICAL AUTOMATION SOLUTIONS TO FACILITATE THE EFFICIENT MANUFACTURING AND FAST, SAFE RELEASE OF HEALTHCARE PRODUCTS, WILL RELEASE FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS PRIOR TO THE MARKET OPEN ON THURSDAY, MARCH 12, 2026.

Rapid Micro Biosystems, Inc.

RPID

Price

Financial Reports

No items found.

Press Releases

Rapid Micro Biosystems, Inc.

RPID.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financial Reports

No items found.

Press Releases

RPID